{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:54:17Z","timestamp":1761393257086,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jaci.2004.10.021","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T10:46:35Z","timestamp":1103885195000},"page":"259-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Leukotriene E4\u2013induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma"],"prefix":"10.1016","volume":"115","author":[{"given":"Annika","family":"Laitinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Halme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Altraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri A.","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.10.021_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1139\/y82-087","article-title":"Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscle","volume":"60","author":"Jones","year":"1982","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jaci.2004.10.021_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2222.1996.tb00621.x","article-title":"The role of leukotrienes in asthma and allergic rhinitis","volume":"26","author":"Busse","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.10.021_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/ajrccm\/144.5.1053","article-title":"Leukotrienes C4, D4, and E4, enhance histamine responsiveness in asthmatic airways","volume":"144","author":"O'Hickey","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.10.021_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/ajrccm\/146.1.104","article-title":"Recovery of leukotriene E4 from the urine of patients with airway obstruction","volume":"146","author":"Drazen","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.10.021_bib5","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1164\/ajrccm\/144.6.1274","article-title":"Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators","volume":"144","author":"Sedgwick","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.10.021_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(93)91073-U","article-title":"Leukotriene E4 and granulocytic infiltration into asthmatic airways","volume":"341","author":"Laitinen","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.10.021_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/ajrccm.150.3.8087328","article-title":"Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist in subjects with bronchial asthma","volume":"150","author":"Spector","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","article-title":"Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma","volume":"158","author":"Reiss","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0140-6736(91)90277-V","article-title":"Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects","volume":"337","author":"Taylor","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2004.10.021_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJM199012203232504","article-title":"Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4 receptor antagonist","volume":"323","author":"Manning","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1164\/ajrccm\/145.4_Pt_1.746","article-title":"Role of leukotriene in exercise-induced asthma: inhibitory effect of ICI204219, a potent leukotriene D4 receptor antagonist","volume":"145","author":"Finnerty","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.10.021_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1164\/ajrccm.157.5.9609014","article-title":"Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge","volume":"157","author":"Calhoun","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib13","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-29","article-title":"Antileukotriene therapy: future directions","volume":"161","author":"Holgate","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0091-6749(91)90189-U","article-title":"Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases","volume":"88","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.10.021_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1164\/ajrccm\/147.3.697","article-title":"Airway mucosal inflammation even in patients with newly diagnosed asthma","volume":"147","author":"Laitinen","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.10.021_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/ajrccm.156.3.9610084","article-title":"Tenascin is increased in airway BM of asthmatics and decreased by an inhaled steroid","volume":"156","author":"Laitinen","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: selection of reference values and interpretative strategies","volume":"144","author":"American Thoracic Society, Medical Section of the American Lung Association","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2004.10.021_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/ajrccm.164.8.2102033","article-title":"Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma","volume":"164","author":"Gauvreau","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1164\/ajrccm.155.4.9105062","article-title":"The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma","volume":"155","author":"Diamant","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/ajrccm.154.4.8887574","article-title":"Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody","volume":"154","author":"Underwood","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2222.2002.01384.x","article-title":"Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism","volume":"32","author":"Fregonese","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.10.021_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1","article-title":"Eosinophil infiltration and degranulation in normal human tissue","volume":"252","author":"Kato","year":"1998","journal-title":"Anat Rec"},{"key":"10.1016\/j.jaci.2004.10.021_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20020044","article-title":"Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists","volume":"195","author":"Mellor","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI17974","article-title":"Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics","volume":"112","author":"Flood-Page","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.10.021_bib25","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.167.5.2855","article-title":"IL-13 and IL-14 up-regulate cysteinyl leukotriene 1 receptor in human monocytes and macrophages","volume":"167","author":"Thivierge","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.10.021_bib26","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.4049\/jimmunol.165.9.5221","article-title":"Interleukin-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils","volume":"165","author":"Thivierge","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.10.021_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/mai.2003.1587","article-title":"Regulation of eosinophil apoptosis by nitric oxide: role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5","volume":"112","author":"Zhang","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2004.10.021_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/pupt.2000.0262","article-title":"Leukotrienes as mediators of asthma","volume":"14","author":"Nicosia","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaci.2004.10.021_bib29","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-9","article-title":"Pharmacological characterization of leukotriene receptors","volume":"161","author":"Dahl\u00e9n","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1164\/ajrccm.163.1.2003101","article-title":"Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes","volume":"163","author":"Figueroa","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2004.10.021_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng0501-87","article-title":"A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population","volume":"28","author":"Laitinen","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2004.10.021_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/9680","article-title":"Pharmacogenetic associations between ALOX5 promoter genotype and the response to anti-asthma treatment","volume":"22","author":"Drazen","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2004.10.021_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1090010","article-title":"Characterization of a common susceptibility locus for asthma-related traits","volume":"304","author":"Laitinen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaci.2004.10.021_bib34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1172\/JCI119241","article-title":"Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription","volume":"99","author":"In","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.10.021_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0952-3278(03)00072-3","article-title":"The cysteine leukotriene receptors","volume":"69","author":"Evans","year":"2003","journal-title":"Prostaglandin Leukot Essent Fatty Acids"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904026776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904026776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:56:25Z","timestamp":1758776185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904026776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0091674904026776"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.10.021","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukotriene E4\u2013induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}